Yahoo Web Search

  1. Yahoo Finance Results

  2. We strongly encourage Congress to pass this critical legislation as soon as possible,” said Dan Kistner, senior vice president, Vizient pharmacy solutions. The CREATES Act will help improve ...

    N/AN/A (N/A%)

    at Wed, Jan 27, 2016, 4:00PM EST - U.S. Markets closed

    After Hours N/A

    Delayed Quote

    • Open 0.00
    • High N/A
    • Low N/A
    • Prev. Close 0.00
    • 52 Wk. High N/A
    • 52 Wk. Low N/A
    • P/E N/A
    • Mkt. Cap N/A
  3. Web results

  4. MedAssets - Vizient Inc

    Vizient has completed its acquisition of MedAssets' Spend and Clinical Resource Management (SCM) and Sg2 businesses.

  5. Medassets - Wikipedia

    MedAssets, Inc. was an American healthcare performance improvement company. It provided products and services to 4,400 hospitals and 122,000 non-acute healthcare ...

  6. The latest Tweets from Medassets (@MedassetsIndia). a pioneering online platform facilitating #investments in #healthcare business in India. Nothing go ...

  7. Stock analysis for MedAssets Inc (MDAS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

  8. nThrive, formerly MedAssets-Precyse, is a revenue cycle management company focused on aiding health care providers with Patient-to-Payment℠ solutions.

  9. MedAssets | LinkedIn

    Learn about working at MedAssets. Join LinkedIn today for free. See who you know at MedAssets, leverage your professional network, and get hired.

  10. Are you considering MedAssets (NASDAQ:MDAS) stock for your investment portfolio? View MDAS's latest stock price, price target, analyst ratings, earnings information ...

  11. Medassets Company Profile | Owler

    MedAssets has 3,350 employees and an estimated annual revenue of $551.9M. They have raised $212.8M in funding. Check out MedAssets' profile for competitors ...

  12. Here's Why MedAssets, Inc. Jumped 30% Today -- The Motley Fool

    What: MedAssets (NASDAQ:MDAS) is up 30% today after announcing that it's being acquired by Pamplona Capital Management. So what: Pamplona is paying $31.35 per share ...

  13. MedAssets Connect Sign In

    Welcome to MedAssets Connect ® Sign In. Username Forgot username?